Large-scale overcapacity Biodiagnosis may become the next air port

the beginning of 2020, due to the outbreak of high stimulation, some medical supplies, equipment has become difficult to find, after 10 months, the hospital's medical supplies still urgently need what? What areas will be the next wind?

1, large-scale overcapacityNovember 12, 2020 Tiancat Double Eleven global carnival season has come to an end, the analysis data seem to be foreshadowing the direction of China's consumer industry, according to Cypress Blue device observation, "Double Eleven" activities, Tmall mask sales decreased by 76.24 percent compared to the outbreak period;What is the current domestic production capacity of protective materials and where will the market develop? The general manager of Henan's well-known medical device manufacturers told Saibai Blue Equipment that under the new situation of the epidemic, the overall production capacity of epidemic prevention materials has been met, and there has been overcapacity, even if the international epidemic continues to be serious, the mass selling of masks still appears."If there is overcapacity on a single product side, it may not be enough to attract widespread attention. Today, the overall industrial chain is overcapacity, in 2019 China's total capacity of nonwovens less than 60,000 tons, in 2020 only Sinopec from February to build 16 fused spray production lines, annual output of more than 10,000 tons. According to incomplete statistics, the total annual output of molten non-wovens is at least 500,000 tons. Zhang Yanan added.Due to the impact of the outbreak at the beginning of the year, many domestic production enterprises are increasing production line production, large-scale layout caused in addition to melting spray cloth, protective clothing protective fabrics, surgical clothing fabrics, surgical shop single fabrics, etc. have appeared large-scale industrial surplus.

2, the number of medical device enterprisesAt present, the domestic epidemic has been well controlled, hospital medical supplies still need what? In this regard, Chengdu Seventh People's Hospital Vice President of the Cypress Blue equipment said:"Most of the medical supplies have no special shortage, China's production capacity is very strong, commonly used equipment such as ventilators and other equipment, as long as there is demand, will soon be met, in accordance with the requirements of the Health Andy Commission, the hospital will be sufficient reserves of the required materials."The stockpile of anti-epidemic materials in China has been greatly increased, especially masks, protective clothing, infrared thermometers and other medical devices, which are closely related to people's daily life.According to data observed during the 2020 National Medical Device Safety Promotion Week sponsored by the State Drug Administration, as of the end of August 2020, the number of medical device manufacturers nationwide was 26,456, an increase of 40% year-on-year in 2019.According to statistics, China's medical protective clothing, medical mask registration certificate application annotation data, than before the outbreak increased by about 1000%. It is important to note that two reusable protective clothing products have been approved for sale. 49 new coronavirus detection kits, 2 blood purification medical equipment, 8 ventilators and other products have been approved by the state department of emergency approval has been approved for listing.

3, biodiagnosis becomes the next"The next wind in the medical industry may be in the field of biotherapy (in the field of gene cells), where domestic enterprises are investing heavily and have a tendency to accelerate rapidly, and the state has put in place a number of policies to support it." The head of the medical industry association told Cypress Blue.Taking one of the hottest genetic testing as an example, the industry is developing rapidly, and a series of policies and regulations have been issued by many departments to promote the development of genomics industry. With the implementation of the policy, will have a positive impact on the development of the genetic testing industry.On June 3, 2020, the Medical Device Technology Review Center of the State Drug Administration issued the Notice on the Collection of Information on The Production Enterprises of Accompanying Diagnostic Reagents to guide the clinical trial work that accompanies the registration and declaration of diagnostic test reagents.Since the outbreak of the new crown outbreak, nucleic acid detection technology-based new crown virus detection kit has played an important role, the National Health and Health Commission issued a request to all places to combine the prevention and control of the new crown pneumonia outbreak, further strengthen the construction of clinical testing laboratories, require capable hospitals above the second level to carry out nucleic acid testing.   At present, the biological industry has become one of the three key areas of national development.   New vaccines, antibody drugs, protein drugs and other biotechnology drugs, diagnosis and detection of major diseases, biological therapy technology, regenerative medicine technology is becoming the focus of development direction. Cell, gene and bioengineering technologies will continue to drive accelerated growth in the healthcare industry over the next 10-20 years. (Cypress Blue Equipment
)